Media Releases | Press Releases & Company News

PRESS RELEASE

Q-NiFlex™ and Phytosome Quantum Nano Sphere (PQNS™) Technology: A Next-Generation Multi-Target Drug Delivery Strategy for Joint Health and Osteoarthritis Management

Q-NiFlex™ and Phytosome Quantum Nano Sphere (PQNS) Technology: A Next-Generation Multi-Target Drug Delivery Strategy for Joint Health and Osteoarthritis Management Published review outlines the multi-target formulation and nano-delivery mechanism; a 500-patient randomized controlled trial is underway to evaluate clinical outcomes A peer-reviewed paper published in the International Journal of Scientific Research (Vol. 15, Issue 7, July 2026; DOI: 10.36106/ijsr) outlines

July 16, 2026 No Comments

Crassula Pharmaceuticals launches QuanticSphere technology in India

PRESS RELEASE

Crassula Pharmaceuticals Launches India’s First QuanticSphere™ Drug-Delivery Technology

Crassula Pharmaceuticals has officially launched its proprietary QuanticSphere™ drug-delivery technology in India, marking a significant milestone in the advancement of pharmaceutical and nutraceutical delivery systems. The launch event, held in Indore, represents the first introduction of QuanticSphere™ in the Indian market and underscores Crassula’s continued focus on science-driven innovation and patient-centric formulation design. QuanticSphere™ is a patented delivery platform engineered

December 22, 2025 No Comments

NEWS

Happy Diwali

Happy Diwali from all of us at Crassula Pharmaceuticals. May this Festival of Lights bring renewed energy, health, and prosperity to every home. As we celebrate illumination in all its forms, we remain committed to advancing science and wellness—with the same spirit of clarity and purpose that Diwali inspires. ✨ Wishing you a bright, safe, and joyous Diwali.

October 21, 2025 No Comments

NEWS

Season’s Greetings from Crassula

Season’s Greetings from Crassula As we wrap up another year of delivering quality solutions and forging new horizons in the health and wellness sector, we want to express our heartfelt appreciation for our clients, partners, and community who have entrusted us with their well-being. This holiday season, we are filled with gratitude for every milestone reached and every partnership formed.

December 22, 2024 No Comments

PRESS RELEASE

India Independence Day

On this special day, we join in celebrating India’s 78th Independence Day, honoring the resilience, unity, and unwavering spirit of its people. As we commemorate the journey to freedom, let us continue striving for progress and prosperity. Wishing everyone a day filled with pride and reflection. Happy Independence Day! 🇮🇳

August 15, 2024 No Comments

HYPERTENSION

Crassula Launches Vascutan Plus, Irbesartan/Hydrochlorothiazide, in Honduras

Crassula Launches Vascutan Plus, Irbesartan/Hydrochlorothiazide, in Honduras Tegucigalpa, Honduras – Continuing its commitment to cardiovascular health, Crassula Pharmaceuticals is proud to announce the release of Vascutan Plus, a combination medication containing Irbesartan and Hydrochlorothiazide, in Honduras. This new addition enhances Crassula’s portfolio by offering a comprehensive treatment solution for hypertension. Vascutan Plus combines Irbesartan, an angiotensin II receptor blocker (ARB),

May 8, 2024 No Comments

DIABETIC

Crassula Pharmaceuticals Launches Vascutan, Irbesartan, in Honduras

Crassula Introduces Vascutan for Advanced Hypertension Control in Honduras Tegucigalpa, Honduras – Crassula Pharmaceuticals, a leader in cardiovascular healthcare solutions, is thrilled to announce the market introduction of Vascutan, an Irbesartan-based medication, in Honduras. This strategic expansion of Crassula’s cardiovascular portfolio underscores the company’s commitment to combating hypertension and associated cardiac conditions. Irbesartan, the active ingredient in Vascutan, is a

April 29, 2024 No Comments

PRESS RELEASE

We are proud to announce a new addition to our team at CRASSULA!

We are proud to announce a new addition to our team at CRASSULA! We are thrilled to announce an exciting new addition to our team at CRASSULA! Please join us in welcoming Daniel Suazo as the new Medical Representative Lead at #CrassulaHonduras. Daniel comes to us with an impressive background in the healthcare sector, where he has consistently demonstrated exceptional

April 16, 2024 No Comments

DIABETIC

Introducing Glycedil: Revolutionizing Type 2 Diabetes Management in Honduras

Introducing Glycedil: Revolutionizing Type 2 Diabetes Management in Honduras Crassula Honduras Announces the Launch of Glycedil, Sitagliptin 100mg, in Honduras Tegucigalpa, Honduras – In a significant expansion of its diabetes care portfolio, Crassula Pharmaceuticals proudly introduces Glycedil, a Sitagliptin 100mg tablet, to the Honduran market. This strategic launch underscores Crassula’s unwavering commitment to innovating in the field of chronic disease

March 26, 2024 No Comments